An analysis of Medicare data suggests that high use of cholesterol-lowering statins was associated with a reduced risk for Alzheimer disease but that reduction in risk varied by type of statin and race/ethnicity, findings that must be confirmed in clinical trials, according to a new article published online by JAMA Neurology.
from Dementia Big http://ift.tt/2hnbbnk via alcoholic dementia
http://ift.tt/2hyelVG
No comments:
Post a Comment